IPO Review and Registration Progress - Four companies passed the IPO review last week, including two semiconductor firms, Qiangyi Co. and Hengrun Chang, aiming to list on the Sci-Tech Innovation Board and Beijing Stock Exchange respectively [2][3] - Qiangyi Co. focuses on the development and production of probe cards, essential for semiconductor testing, with a high customer concentration where the top five clients contribute about 80% of revenue [2][3] - Hengrun Chang specializes in plasma RF power systems, with revenue projected to grow from 158 million yuan in 2022 to 541 million yuan in 2024, although a slight decline in revenue is expected in 2025 due to increased R&D and capacity expansion [3][4] New IPO Applications and Upcoming Listings - Five companies are scheduled for IPO reviews this week, including Zhenstone Co., which plans to raise 3.981 billion yuan, focusing on clean energy materials [5][6] - Zhenstone's revenue is expected to decline from 5.267 billion yuan in 2022 to 4.439 billion yuan in 2024, primarily due to market competition and raw material price fluctuations [6] - Other companies like Yisiwei and Aide Technology are also preparing for IPOs, with Yisiwei's revenue heavily reliant on government subsidies [7][8] New Stock Listings and Subscription Dynamics - Three new stocks are set to be listed this week, including Beikang Detection, Hengkun New Materials, and Nanfang Network Digital, with significant revenue growth reported for Nanfang Network Digital [12][13] - Beikang Detection focuses on non-ferrous metal inspection services, while Hengkun New Materials specializes in key materials for semiconductor manufacturing [12][13] - Two new stocks are scheduled for subscription, including Jingchuang Electric and China Uranium, with China Uranium projected to achieve revenue between 19.5 billion and 20 billion yuan in 2025 [14][15]

Summary of Key Points Core Viewpoint The Beijing Stock Exchange (BSE) has seen a decrease in trading volume and value over the past week, with a total of 282 listed companies as of November 9, 2025. The market is also witnessing new listings and ongoing IPO activities, indicating a dynamic but challenging environment for investors. Trading Activity - As of November 9, 2025, the BSE has 282 listed companies with a total share capital of 39.225 billion shares and a circulating share capital of 25.056 billion shares [2] - For the week of November 3 to November 9, the trading volume was 4.925 billion shares, a decrease of 17.24% week-on-week, while the trading value was 1136.16 billion yuan, down 21.40% from the previous week [3] - The average trading price during this period was 23.07 yuan, reflecting a decrease of 5.03% [3] - The BSE 50 Index fell by 3.79% to 1522.73 points, with 9 stocks rising and 41 stocks declining [3] New Listings and IPOs - Two companies successfully listed on the BSE during the week of November 3 to November 9, 2025 [7] - The newly listed companies include: - **Danna (Tianjin) Biotechnology Co., Ltd.**: Listed on November 3, 2025, with a first-day trading surge of 497.08% and a closing price of 102.10 yuan [8][10] - **Zhongcheng Consulting Group Co., Ltd.**: Listed on November 7, 2025, with a first-day increase of 170.08% and a closing price of 35.60 yuan [13][30] - Both companies aim to raise approximately 1.37 billion yuan for various projects, including R&D and infrastructure [10][30] Financial Performance of Newly Listed Companies - **Danna Biotechnology**: - Revenue for 2022-2024: 295 million yuan, 237 million yuan, 240 million yuan; Net profit: 44.62 million yuan, 77.60 million yuan, 87.19 million yuan [10] - 2025 H1 revenue decreased by 1.38% to 116 million yuan, while net profit increased by 29.55% to 49.96 million yuan [11] - **Zhongcheng Consulting**: - Revenue for 2022-2024: 303 million yuan, 368 million yuan, 396 million yuan; Net profit: 64.36 million yuan, 81.06 million yuan, 105 million yuan [13] - 2025 H1 revenue decreased by 4.08% to 191 million yuan, and net profit decreased by 2.66% to 53.29 million yuan [14] Ongoing IPO Activities - As of November 9, 2025, there are 104 companies awaiting approval for listing on the BSE, with various stages of the IPO process [6] - Two companies submitted registration during the week, while three companies passed the listing committee meetings [25][26] - Notable companies that passed the listing committee include: - **Qilong Ocean**: Engaged in oil drilling equipment manufacturing, aiming to raise 382 million yuan [27] - **Haiseng Medical**: Focused on medical device manufacturing, seeking to raise 370 million yuan [30] - **Guoliang New Materials**: Specializing in refractory materials, aiming to raise 175 million yuan [33] Market Dynamics - The BSE is experiencing fluctuations in trading activity and new listings, reflecting both opportunities and challenges in the current market environment [3][6][25]